Skip to main content

Table 2 Secondary outcomes compare in three groups

From: Premedication with dexmedetomidine for prevention of hyperdynamic response after electroconvulsive therapy: a cross-over, randomized controlled trial

  DEX0.5
(n = 24)
DEX1.0
(n = 24)
NSS
(n = 24)
P-value
ECT Energy (J)a 55 (40–72.5) 55 (37.5–85) 55 (35–70) 0.762
Recovery time (min) 19.17 ± 9.95 24.54 ± 13.07 18.5 ± 12.91 0.152
Motor seizure duration (min) 39.54 ± 15.38 30.92 ± 13.68 40.13 ± 13.32 0.048
EEG seizure duration (min) 53 ± 24.83 40.83 ± 16.68 52.38 ± 18.66 0.073
Asystole duration 6.79 ± 1.69 7.5 ± 2.19 8.88 ± 11.11 0.375
Agitation score b     0.052
 1 14 (58.33%) 19 (79.17%) 15 (62.5%)  
 2 10 (41.67%) 5 (20.83%) 6 (25%)  
 3 0 0 3 (12.5%)  
  1. Data presented as mean ± standard deviation, amedian (interquartile range), bn (%)